Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.

ABSTRACT:

SUBMITTER: Kanie T 

PROVIDER: S-EPMC8812344 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature